MetaCap

Aspen Neuroscience (ASPE) vs Larimar Therapeutics (LRMR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Aspen Neuroscience is the larger company by market cap ($361.2 million vs $328.6 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASPE-16.59%LRMR+27.13%
+33%+5%-24%
Oct 30, 20261 yearNov 20, 2026
ASPE-16.59%LRMR+27.13%
+29%+5%-19%
Oct 26, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASPE versus LRMR key metrics
MetricASPELRMR
Share price$12.42$3.14
Market cap$361.16M$328.55M
1-day change+0.24%-2.48%
YTD return—-17.59%
1-year return—-11.80%
5-year return—-68.97%
EPS (TTM)$-4.89$-1.67
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)—$-165.67M
52-week high$14.90$6.42
52-week low$11.20$1.92
Distance from 52-week high-16.64%-51.09%
Analyst consensus—strong_buy
Avg. price target upside—+352.23%
Average volume352.42K1.38M
Shares outstanding29.08M104.63M
Employees12071
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Aspen Neuroscience

ASPE stock →

Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 120 employees

About Larimar Therapeutics

LRMR stock →

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease.

Health Care · Biotechnology: Pharmaceutical Preparations · 71 employees

ASPE vs LRMR FAQ

Which is bigger, Aspen Neuroscience or Larimar Therapeutics?

Aspen Neuroscience (ASPE) is larger, with a market capitalization of $361.16M compared with $328.55M for Larimar Therapeutics (LRMR).

Are Aspen Neuroscience and Larimar Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons